Saturday, November 6, 2021
- 8:30AM-10:30AM
-
Abstract Number: 0150
Clinical Characteristics and Quantitative CT Findings in Connective Tissue Disease-Associated Interstitial Lung Disease
Imaging of Rheumatic Diseases Poster (0149–0182)- 8:30AM-10:30AM
-
Abstract Number: 0122
Clinical Impact of a Digital Behavioral Therapy for Fibromyalgia Management: A Randomized Controlled Trial
Fibromyalgia & Other Clinical Pain Syndromes Poster (0118–0127)- 8:30AM-10:30AM
-
Abstract Number: 0092
Clinical Outcomes of Patients with Systemic Rheumatic Diseases Hospitalized for COVID-19 at a Large Academic Center in New York City
Epidemiology & Public Health Poster I: COVID-19 & Vaccination (0084–0117)- 8:30AM-10:30AM
-
Abstract Number: 0003
Clinically Identifiable Autoreactivity Is Common in Severe SARS-CoV-2 Infection
B Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster (0001–0010)- 8:30AM-10:30AM
-
Abstract Number: 0135
Comparing Rheumatoid Arthritis (RA), Psoriatic Arthritis (PA) and Systemic Lupus Erythematosus (SLE) Total Cost of Care (TCC) in Those with Optimally Managed Depression to Those with Sub-optimally Managed Depression
Health Services Research Poster I: Lupus, Inflammatory Arthritis, & More (0128–0148)- 8:30AM-10:30AM
-
Abstract Number: 0378
Comparison of Demographic, Clinic and Radiological Features of Axial Spondyloarthritis Patients with and Without Accompanying Familial Mediterranean Fever
Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes Poster I: Clinical Aspects of Axial Spondyloarthritis (0357–0386)- 8:30AM-10:30AM
-
Abstract Number: 0294
Comparison of Factors Associated with CT-Scan Progression of Interstitial Lung Disease in Rheumatoid Arthritis and Idiopathic Pulmonary Fibrosis. Retrospective Multicenter Study of 144 Patients
RA – Diagnosis, Manifestations, & Outcomes Poster I: Cardiovascular Pulmonary Disease (0268–0295)- 8:30AM-10:30AM
-
Abstract Number: 0256
Consensus Approach to a Treat to Target Strategy in Juvenile Idiopathic Arthritis Care: Report from the 2020 Pediatric Rheumatology Care and Outcomes Improvement Network Consensus Conference
Pediatric Rheumatology – Clinical Poster I: JIA (0241–0265)- 8:30AM-10:30AM
-
Abstract Number: 0186
Continued Treatment with Nintedanib in Patients with Progressive Fibrosing Autoimmune Disease-Related Interstitial Lung Diseases: Data from INBUILD-ON
Miscellaneous Rheumatic & Inflammatory Diseases Poster I (0183–0209)- 8:30AM-10:30AM
-
Abstract Number: 0318
Correlation Between Prognostic Nutritional Index and Primary Sjögren’s Syndrome Disease Activity
Sjögren's Syndrome – Basic & Clinical Science Poster (0296–0322)- 8:30AM-10:30AM
-
Abstract Number: 0175
Correlation of Subclinical Synovitis with Juvenile Idiopathic Arthritis Outcome Measurements
Imaging of Rheumatic Diseases Poster (0149–0182)- 8:30AM-10:30AM
-
Abstract Number: 0109
COVID-19 Infection and Outcomes in Patients with Rheumatic Diseases: A Systematic Review and Meta-Analysis
Epidemiology & Public Health Poster I: COVID-19 & Vaccination (0084–0117)- 8:30AM-10:30AM
-
Abstract Number: 0106
COVID-19 Mortality and Hospitalization Risk in Patients with Rheumatic Diseases: A Single Center Retrospective Cohort Study
Epidemiology & Public Health Poster I: COVID-19 & Vaccination (0084–0117)- 8:30AM-10:30AM
-
Abstract Number: 0116
COVID-19 mRNA Vaccine Side Effects Among Individuals with Rheumatic Disease